Clinical Trials Directory

Trials / Unknown

UnknownNCT00914654

Concentrations of Formoterol in Blood and Urine

Blood and Urinary Concentrations of Inhaled Formoterol in Asthmatic Subjects and Elite Athletes With Asthma

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Bispebjerg Hospital · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to assess the blood and urine concentrations of inhaled formoterol.

Detailed description

The purpose of the study is to assess the serum and urine concentrations after inhalation of 18 microgram formoterol as one dose. Furthermore to investigate the serum and urine concentrations of inhaled formoterol and evaluate the difference between three groups: healthy men, male asthmatic subjects and male elite athletes with asthma.

Conditions

Interventions

TypeNameDescription
DRUGinhaled formoterolInhalation of 18 microgram formoterol as one dose. Oxis Turbohaler 9 microg/dose, MA no. 30072.

Timeline

Start date
2009-07-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2009-06-05
Last updated
2009-06-05

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT00914654. Inclusion in this directory is not an endorsement.